HEALTHCARE COSTS AND EXPENDITURES FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA IN THE UNITED STATES

被引:0
|
作者
Karim, Mohammad [1 ]
Ramezani, Mahin [2 ]
Leroux, Todd [2 ]
Kum, Hye Chung [3 ]
Singal, Amit G. [4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA
[2] Texas A&M, College Stn, TX USA
[3] Texas A&M Univ, College Stn, TX USA
[4] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
4515
引用
收藏
页码:S1392 / S1392
页数:1
相关论文
共 50 条
  • [1] Healthcare Costs for Medicare Patients With Hepatocellular Carcinoma in the United States
    Karim, Mohammad A.
    Ramezani, Mahin
    Leroux, Todd
    Kum, Hye-Chung
    Singal, Amit G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (09) : 2327 - +
  • [2] Economic costs of hepatocellular carcinoma in the United States
    Gondek, K.
    Lang, K.
    Danchenko, N.
    Shah, S.
    Anderson, S.
    Thompson, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] HEALTHCARE EXPENDITURES FOR THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA IN JAPAN
    Fukuda, H.
    Ishida, H.
    Sato, D.
    Moriwaki, K.
    VALUE IN HEALTH, 2018, 21 : S34 - S34
  • [4] Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States
    Kaplan, David E.
    Chapko, Michael K.
    Mehta, Rajni
    Dai, Feng
    Skanderson, Melissa
    Aytaman, Ayse
    Baytarian, Michelle
    D'Addeo, Kathryn
    Fox, Rena
    Hunt, Kristel
    Pocha, Christine
    Valderrama, Adriana
    Taddei, Tamar H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (01) : 106 - +
  • [5] DIRECT HEALTHCARE COSTS BY TREATMENT AMONG PATIENTS WITH MERKEL CELL CARCINOMA (MCC) IN THE UNITED STATES
    Kearney, M.
    Thokagevistk, K.
    Boutmy, E.
    Sherman, S.
    Bharmal, M.
    VALUE IN HEALTH, 2018, 21 : S36 - S36
  • [6] Treatment patterns and costs of care for patients diagnosed with hepatocellular carcinoma (HCC) in the United States (US)
    Hess, L.
    Cui, Z.
    Li, X.
    Wu, Y.
    Girvan, A.
    Abada, P.
    ANNALS OF ONCOLOGY, 2018, 29 : 27 - 27
  • [7] HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS TREATED WITH TYROSINE KINSASE INHIBITORS AS SECOND-LINE TREATMENT FOR ADVANCED HEPATOCELLULAR CARCINOMA IN THE UNITED STATES
    Bayo, K.
    Abedtash, H.
    Cui, Z.
    Ogburn, K.
    Girvan, A.
    VALUE IN HEALTH, 2020, 23 : S32 - S32
  • [8] The healthcare costs of sarcopenia in the United States
    Janssen, I
    Shepard, DS
    Katzmarzyk, PT
    Roubenoff, R
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (01) : 80 - 85
  • [9] Out-of-Pocket Annual Health Expenditures and Financial Toxicity From Healthcare Costs in Patients With Heart Failure in the United States
    Wang, Stephen Y.
    Valero-Elizondo, Javier
    Ali, Hyeon-Ju
    Pandey, Ambarish
    Cainzos-Achirica, Miguel
    Krumholz, Harlan M.
    Nasir, Khurram
    Khera, Rohan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (14):
  • [10] HEALTHCARE UTILIZATION AND COSTS AMONG PATIENTS WITH HIP FRACTURE IN THE UNITED STATES
    Zhao, Yang
    Chen, Shih-Yin
    Lee, Yuan-Chi
    Wu, Ning
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S120 - S121